Gilead nears deal to buy Immunomedics for more than $20 billion: Report
(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more
Read more
Immunomedics
Trending Space
Keep Trending